In recent trading session, Bausch Health Companies Inc (NYSE:BHC) saw 0.74 million shares changing hands at last check today with its beta currently measuring 0.36. Company’s recent per share price level of $6.76 trading at $0.35 or 5.47% at last check today assigns it a market valuation of $2.50B. That most recent trading price of BHC’s stock is at a discount of -45.71% from its 52-week high price of $9.85 and is indicating a premium of 41.42% from its 52-week low price of $3.96. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 3.97 million shares which gives us an average trading volume of 2.50 million if we extend that period to 3-months.
For Bausch Health Companies Inc (BHC), analysts’ consensus is at an average recommendation of Hold while assigning it a mean rating of 3.14. Splitting up the data highlights that, out of 4 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 3 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0.93 in the current quarter.
Bausch Health Companies Inc (NYSE:BHC) trade information
Upright in the green today for gaining 5.47%, in the last five days BHC remained trading in the green while hitting it’s week-highest on Friday, 06/27/25 when the stock touched $6.76 price level, adding 0.44% to its value on the day. Bausch Health Companies Inc’s shares saw a change of -0.58% in year-to-date performance and have moved 9.40% in past 5-day. Bausch Health Companies Inc (NYSE:BHC) showed a performance of 48.59% in past 30-days. Number of shares sold short was 8.68 million shares which calculate 4.49 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 9 to the stock, which implies a rise of 24.89% to its recent value today. Analysts have been projecting 7 as a low price target for the stock while placing it at a high target of 16. It follows that stock’s current price would drop -3.55% in reaching the projected high whereas dropping to the targeted low would mean a loss of -3.55% for stock’s current value.
Bausch Health Companies Inc (BHC) estimates and forecasts
This year revenue growth is estimated to rise 4.01% from the last financial year’s standing.
5 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 2.47B for the same. And 5 analysts are in estimates of company making revenue of 2.58B in the next quarter. Company posted 2.4B and 2.51B of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 52.33% during past 5 years. In 2025, company’s earnings growth rate is likely to be around -0.74% while estimates for its earnings growth in next 5 years are of 6.74%.
Bausch Health Companies Inc (NYSE:BHC)’s Major holders
Insiders are in possession of 10.96% of company’s total shares while institution are holding 69.06 percent of that, with stock having share float percentage of 77.57%. Investors also watch the number of corporate investors in a company very closely, which is 69.06% institutions for Bausch Health Companies Inc that are currently holding shares of the company. ICAHN CARL C is the top institutional holder at BHC for having 34.72 million shares of worth $242.01 million. And as of 2024-06-30, it was holding 9.4377 of the company’s outstanding shares.
The second largest institutional holder is PAULSON & CO. INC., which was holding about 26.44 million shares on 2024-06-30. The number of shares represents firm’s hold over 7.1865 of outstanding shares, having a total worth of $184.28 million.
On the other hand, VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund and Franklin Custodian Funds-FRANKLIN INCOME FUND are the top two Mutual Funds which own company’s shares. As of Jan 31, 2025 , the former fund manager was holding 4.21 shares of worth $28.0 million or 1.14% of the total outstanding shares. The later fund manager was in possession of 4.0 shares on Mar 31, 2025 , making its stake of worth around $26.58 million in the company or a holder of 1.08% of company’s stock.
